Pitfalls in the measurement and interpretation of thyroid function tests☆
暂无分享,去创建一个
Mark Gurnell | O. Koulouri | M. Gurnell | D. Halsall | David Halsall | Krishna Chatterjee | K. Chatterjee | Olympia Koulouri | Carla Moran | C. Moran
[1] S. Atkin,et al. Autoimmune Hypothyroidism Coexisting with a Pituitary Adenoma Secreting Thyroid-Stimulating Hormone, Prolactin and α-Subunit , 2001, Annals of clinical biochemistry.
[2] R. Fletterick,et al. Incidental identification of a thyroid hormone receptor beta (THRB) gene variant in a family with autoimmune thyroid disease. , 2013, Thyroid : official journal of the American Thyroid Association.
[3] J. Hershman,et al. Conditions and drugs interfering with thyroxine absorption. , 2009, Best practice & research. Clinical endocrinology & metabolism.
[4] B. Biondi. The normal TSH reference range: what has changed in the last decade? , 2013, The Journal of clinical endocrinology and metabolism.
[5] Michael J Murphy,et al. Age- and gender-specific TSH reference intervals in people with no obvious thyroid disease in Tayside, Scotland: the Thyroid Epidemiology, Audit, and Research Study (TEARS). , 2013, The Journal of clinical endocrinology and metabolism.
[6] A. Hollenberg,et al. The in vivo role of nuclear receptor corepressors in thyroid hormone action. , 2013, Biochimica et biophysica acta.
[7] A. Uitterlinden,et al. Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation , 2004, The Lancet.
[8] A. Farwell. Thyroid hormone therapy is not indicated in the majority of patients with the sick euthyroid syndrome. , 2008, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[9] Donald L St Germain,et al. Minireview: Defining the roles of the iodothyronine deiodinases: current concepts and challenges. , 2009, Endocrinology.
[10] J. Morris. How do you approach the problem of TSH elevation in a patient on high‐dose thyroid hormone replacement? , 2009, Clinical endocrinology.
[11] F. Latrofa,et al. Causes and laboratory investigations of thyrotoxicosis , 2011 .
[12] P. Chanson,et al. The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients. , 2003, European journal of endocrinology.
[13] K. Brockmann,et al. A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. , 2004, American journal of human genetics.
[14] L. Thienpont,et al. IFCC international conventional reference procedure for the measurement of free thyroxine in serum , 2011, Clinical chemistry and laboratory medicine.
[15] T. van der Poll,et al. Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. , 1990, The Journal of clinical endocrinology and metabolism.
[16] E. Anckaert,et al. FT4 immunoassays may display a pattern during pregnancy similar to the equilibrium dialysis ID-LC/tandem MS candidate reference measurement procedure in spite of susceptibility towards binding protein alterations. , 2010, Clinica chimica acta; international journal of clinical chemistry.
[17] M. Gurnell,et al. Reversible pituitary enlargement in the syndrome of resistance to thyroid hormone. , 1998, Thyroid : official journal of the American Thyroid Association.
[18] M. Inada,et al. [Thyroid hormone metabolism]. , 1993, Nihon Naibunpi Gakkai zasshi.
[19] P. Dahlqvist,et al. National incidence and prevalence of TSH-secreting pituitary adenomas in Sweden. , 2012, The Journal of clinical endocrinology and metabolism.
[20] F. B. Davis,et al. Nongenomic actions of thyroid hormone on the heart. , 2002, Thyroid : official journal of the American Thyroid Association.
[21] J. N. Walker,et al. A thyroxine absorption test followed by weekly thyroxine administration: a method to assess non-adherence to treatment. , 2013, European journal of endocrinology.
[22] K. Cusi,et al. Thyroid function testing in psychiatric illness: Usefulness and limitations , 1997, Trends in Endocrinology & Metabolism.
[23] G. Steiner,et al. Influence of heparin on serum free thyroxine. , 1969, The Journal of clinical endocrinology and metabolism.
[24] R. Weiss,et al. Autoimmunity in patients with resistance to thyroid hormone. , 2010, The Journal of clinical endocrinology and metabolism.
[25] S. Kunitake,et al. Mechanism of the heparin-induced increase in the concentration of free thyroxine in plasma. , 1987, The Journal of clinical endocrinology and metabolism.
[26] I. Young,et al. Misleading serum free thyroxine results during low molecular weight heparin treatment. , 1998, Clinical chemistry.
[27] J. Jaume,et al. Extremely low doses of heparin release lipase activity into the plasma and can thereby cause artifactual elevations in the serum-free thyroxine concentration as measured by equilibrium dialysis. , 1996, Thyroid : official journal of the American Thyroid Association.
[28] T. Visser,et al. Minireview: thyroid hormone transporters: the knowns and the unknowns. , 2010, Molecular endocrinology.
[29] E. Fliers,et al. Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness. , 1997, The Journal of clinical endocrinology and metabolism.
[30] P. Rae,et al. The Clinical Utility of a Non-Isotopic Two-Step Assay (DELFIA) and an Analogue Radioimmunoassay (SimulTRAC) for Free Thyroxine Compared , 1991, Annals of clinical biochemistry.
[31] B. Arafah,et al. Sex steroids and the thyroid. , 2009, Best practice & research. Clinical endocrinology & metabolism.
[32] B. Haugen. Drugs that suppress TSH or cause central hypothyroidism. , 2009, Best practice & research. Clinical endocrinology & metabolism.
[33] G. Umpierrez,et al. Best Practice & Research Clinical Endocrinology & Metabolism , 2011 .
[34] J E Midgley,et al. Direct and indirect free thyroxine assay methods: theory and practice. , 2001, Clinical chemistry.
[35] P. Beck‐Peccoz,et al. Different responses to chronic somatostatin analogues in patients with central hyperthyroidism , 2005, Clinical endocrinology.
[36] K. Downes,et al. A mutation in the thyroid hormone receptor alpha gene. , 2012, The New England journal of medicine.
[37] T. Nagaya,et al. Thyroid Hormone Resistance Syndrome , 1991 .
[38] Soo-Mi Park,et al. An adult female with resistance to thyroid hormone mediated by defective thyroid hormone receptor α. , 2013, The Journal of clinical endocrinology and metabolism.
[39] L. D. De Groot. Dangerous dogmas in medicine: the nonthyroidal illness syndrome. , 1999, The Journal of clinical endocrinology and metabolism.
[40] A. Bianco,et al. Deiodinases: implications of the local control of thyroid hormone action. , 2006, The Journal of clinical investigation.
[41] J. Stockigt,et al. EFFECT OF ORAL FRUSEMIDE ON DIAGNOSTIC INDICES OF THYROID FUNCTION , 1987, Clinical endocrinology.
[42] P. Laurberg,et al. Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease. , 2002, The Journal of clinical endocrinology and metabolism.
[43] A. Leung. Thyroid function in pregnancy. , 2012, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.
[44] H. Ramos,et al. [Thyroid hormone resistance syndrome]. , 2004, Arquivos brasileiros de endocrinologia e metabologia.
[45] J. Stockigt,et al. Medications that distort in vitro tests of thyroid function, with particular reference to estimates of serum free thyroxine. , 2009, Best practice & research. Clinical endocrinology & metabolism.
[46] M. Gurnell,et al. What should be done when thyroid function tests do not make sense? , 2011, Clinical endocrinology.
[47] O. Soldin,et al. Assessing Thyroid Function in Pregnancy , 2010 .
[48] V. Darras,et al. Impact of monocarboxylate transporter-8 deficiency on the hypothalamus-pituitary-thyroid axis in mice. , 2010, Endocrinology.
[49] L. Schomburg,et al. Mutations in SECISBP2 result in abnormal thyroid hormone metabolism , 2005, Nature Genetics.
[50] P. Hamblin,et al. Relationship between thyrotropin and thyroxine changes during recovery from severe hypothyroxinemia of critical illness. , 1986, The Journal of clinical endocrinology and metabolism.
[51] F. Brucker-Davis,et al. Thyrotropin-secreting pituitary tumors. , 1996, Endocrinology and metabolism clinics of North America.
[52] R. Weiss,et al. Resistance to Thyroid Hormone , 2004, Reviews in Endocrine and Metabolic Disorders.
[53] E. Fliers,et al. Impaired bacterial clearance in type 3 deiodinase-deficient mice infected with Streptococcus pneumoniae. , 2009, Endocrinology.
[54] G. Barbesino,et al. Drugs affecting thyroid function. , 2010, Thyroid : official journal of the American Thyroid Association.
[55] C. Mendel,et al. Effect of free fatty acids on the concentration of free thyroxine in human serum: the role of albumin. , 1986, The Journal of clinical endocrinology and metabolism.
[56] L. Degroot,et al. Megatrials for Clinical Decision Making , 1996, Annals of Internal Medicine.
[57] E. Krenning,et al. The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism , 1993, Clinical endocrinology.
[58] G. Klee. Harmonization and standardization of thyroid function tests. , 2010, Clinical chemistry.
[59] G. Brent,et al. Maternal thyroid function: interpretation of thyroid function tests in pregnancy. , 1997, Clinical obstetrics and gynecology.
[60] K. Burman,et al. Alterations in thyroid function in patients with systemic illness: the "euthyroid sick syndrome". , 1982, Endocrine reviews.
[61] L. J. Groot,et al. Dangerous Dogmas in Medicine: The Nonthyroidal Illness Syndrome , 1999 .
[62] J. Michl,et al. A characteristic serpin cleavage product of thyroxine-binding globulin appears in sepsis sera. , 2000, The Journal of clinical endocrinology and metabolism.
[63] J. Lado-Abeal,et al. Thyroid hormone receptors are down-regulated in skeletal muscle of patients with non-thyroidal illness syndrome secondary to non-septic shock. , 2010, European journal of endocrinology.
[64] F. Muntoni,et al. Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans. , 2010, The Journal of clinical investigation.
[65] P. Beck‐Peccoz,et al. Pituitary tumours: TSH-secreting adenomas. , 2009, Best practice & research. Clinical endocrinology & metabolism.
[66] T. Visser,et al. Clinical phenotype of a new type of thyroid hormone resistance caused by a mutation of the TRα1 receptor: consequences of LT4 treatment. , 2013, The Journal of clinical endocrinology and metabolism.
[67] G. Beckett,et al. Mechanisms behind the non-thyroidal illness syndrome: an update. , 2010, The Journal of endocrinology.
[68] Stephen Fenlon,et al. The anaesthetist and the Medicines and Healthcare products Regulatory Agency , 2012 .